Results 11 to 20 of about 59,004 (282)
New England Journal of Medicine, 2021 Background and Objectives Discoveries of dermatomyositis-specific antibodies (DMSAs) in patients with dermatomyositis raised awareness of various myopathologic features among antibody subtypes.
J. Tanboon +8 more
semanticscholar +5 more sources
JTO Clinical and Research Reports, 2021 SCLC is frequently associated with paraneoplastic syndromes, including dermatomyositis. Patients with malignancy-associated dermatomyositis express a specific autoantibody pattern usually positive for anti–transcription intermediary factor 1-γ (TIF1-γ ...
Johnathan Arnon, MD +4 more
doaj +1 more source
Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis
Clinical reviews in allergy and immunology, 2022 Dermatomyositis is a chronic inflammatory disease involving the skin and muscles. It most commonly occurs in adults with preponderance in females, but pediatric occurrence is also possible.
Milena Marzęcka +2 more
semanticscholar +1 more source
, 2008 Dermatomyositis (DM) is a chronic inflammatory disorder of the skin and muscles. Although thought to be autoimmune in origin, many questions remain as to the etiopathogenesis of this disease. DM has classically been considered a humorally mediated disease.
M S, Krathen, D, Fiorentino, V P, Werth
openaire +4 more sources
Arthritis & Rheumatology, 2020 Interstitial lung disease (ILD) accompanied by anti–melanoma differentiation–associated gene 5 (anti–MDA‐5)–positive dermatomyositis (DM) is often rapidly progressive and associated with poor prognosis.
H. Tsuji +20 more
semanticscholar +1 more source
Incidence, Prevalence, and Mortality of Dermatomyositis: A Population‐Based Cohort Study
Arthritis care & research, 2021 We aimed to determine the population‐based incidence, prevalence, and mortality of dermatomyositis (DM) using European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) criteria.
V. Kronzer +5 more
semanticscholar +1 more source
Respiratory Medicine Case Reports, 2021 Tracheobronchial lesions are rare extramuscular complications for idiopathic inflammatory myopathies including dermatomyositis. We herein report a 65-year-old woman with tracheal ulcer during the progression of dermatomyositis-associated interstitial ...
Shintaro Sato +9 more
doaj +1 more source
New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review
Rheumatology International, 2022 Dermatomyositis is a rare, type I interferon-driven autoimmune disease, which can affect muscle, skin and internal organs (especially the pulmonary system).
M. Holzer +6 more
semanticscholar +1 more source
Development and validation of a nomogram risk prediction model for malignancy in dermatomyositis patients: a retrospective study [PDF]
PeerJ, 2021 Background Dermatomyositis accompanied with malignancy is a common poor prognostic factor of dermatomyositis. Thus, the early prediction of the risk of malignancy in patients with dermatomyositis can significantly improve the prognosis of patients ...
Jiaojiao Zhong +5 more
doaj +2 more sources
Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis [PDF]
, 2018 Background Few risk factors have been identified for the development of calcinosis among patients with Juvenile Dermatomyositis, and currently no clinical phenotype has been associated with its development.
Al-Hammadi, Noor +4 more
core +2 more sources